A simulated clinical use testing to evaluate the Medlance Plus and myLance sharps injury prevention feature in accordance with the FDA's guidance on medical devices with sharps injury prevention features.
This study aims to evaluate the safety of the use of the following safety lancets: Medlance Plus and myLance in the prevention of needle-stick injury (NSI) and to evaluate the user's opinion with regard to the handling characteristics of the medical devices. The simulated use clinical study involves healthcare professionals (HCPs) who routinely use safety lancets to collect blood samples.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
20
There are sterile, single-use safety lancets designed for the sampling of capillary blood from the fingertip of patients.
Chicago office
Chicago, Illinois, United States
Boston office
Boston, Massachusetts, United States
The true failure rate of the tested devices.
Time frame: At time of testing, up to 90 minutes
Effectiveness of the safety lancet's sharps injury prevention features.
Evaluator questionnaire using five-point response Likert scale (coded from 1 "strongly disagree" to 5 "strongly agree") to measure respondents' attitudes to a particular question or statement. Numbers assigned to Likert scale express a "greater than" relationship.
Time frame: At time of testing, up to 90 minutes
Evaluation of the safety of the devices based on the evaluators' assessments.
Time frame: At time of testing, up to 90 minutes ]
Evaluation of various aspects of the ease of use.
Time frame: At time of testing, up to 90 minutes ]
Detection of any handling, usability questions / issues associated with the device.
Time frame: At time of testing, up to 90 minutes ]
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.